In 24/7 Market News’ view, spider silk in 2025 mirrors the opportunity nylon presented in 1939, but with far greater upside due to global sustainability demands, multi-industry applications, and the ...

In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...

First company to enable precision in vivo genome engineering, combining both cell-specific delivery and programmable, locus-specific gene insertion, with the potential to achieve physiological, durabl ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

The global AI chip market has grown to $166.9 billion in 2025, and is predicted to reach $311.58 billion by 2029, ...

Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by catching it earlier, when it's more treatable and survival rates are highest.

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

Thematic indexing is Among the fastest-growing segments in the ETF market. At Bloomberg’s ETFs in Depth event in London, ...

How they’re doing it: The new company, called Preventive, is being formed to research so-called “heritable genome editing,” ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

Recent technological advances have opened new possibilities for neuroscience research, allowing researchers to map the ...